This is a serious complication that can happen after a hydatidiform mole (molar pregnancy). It's a type of uterine tumor that grows into the muscle wall of the uterus. It can cause bleeding and other problems.
Every report comes from a Lived member, sent anonymously.
Have you tried Methotrexate for Invasive Molar Pregnancy?
An invasive molar pregnancy, usually called an invasive mole, happens when tissue from a molar pregnancy grows into the muscle wall of the uterus instead of clearing completely. A molar pregnancy is one in which the placenta develops abnormally into a mass of fluid-filled sacs, without a pregnancy that can continue normally. Most molar tissue is removed in full, but sometimes cells left behind keep growing and push into the uterine wall. An invasive mole belongs to a group called gestational trophoblastic neoplasia (GTN): tumors that grow from the cells that normally form the placenta. It is treated as a cancer because it can invade surrounding tissue, cause serious bleeding and occasionally spread beyond the uterus, for example to the vagina or lungs. It is also one of the most treatable tumors: with chemotherapy, nearly everyone with low-risk disease is cured, and most people can still have children afterward.
An invasive mole almost always follows a molar pregnancy, most often a complete mole, in which the egg carries no genetic material from the mother and the tissue grows from the father's genes alone. After a complete mole is removed, roughly 10 to 20 percent of people have pregnancy hormone levels that stay high or rise again and are diagnosed with GTN, and invasive mole is one of its most common forms. It is less common after a partial mole and rarer still after other kinds of pregnancy. The known risk factors are mainly those for molar pregnancy itself. Moles are about twice as common in teenagers and in people over 35 as in those aged 20 to 35, and five to seven times as common over 40. They are also more frequent in parts of Asia, Africa and Central America than in the United States or Europe. A molar pregnancy comes from an error at fertilization. It is not caused by anything a person did, and there is no known way to prevent it.
Most invasive moles are found through follow-up blood tests rather than symptoms. After a molar pregnancy is removed, the level of hCG (human chorionic gonadotropin, the pregnancy hormone made by placental tissue) is measured every one to two weeks. If all the abnormal tissue is gone, hCG keeps falling until it reaches normal. Persistent disease is diagnosed when it stops falling or climbs again. Under the criteria of the International Federation of Gynecology and Obstetrics (FIGO), a plateau means four weekly results over at least three weeks that change by less than 10 percent, and a rise means an increase of more than 10 percent across three weekly results over at least two weeks. Some people notice irregular vaginal bleeding first. Once hCG points to persistent disease, a pelvic ultrasound examines the uterus and a chest X-ray checks the lungs. If spots in the lungs measure 1 centimeter or more, scans of the brain, abdomen and pelvis follow. A biopsy is rarely part of the workup, so the diagnosis usually rests on the hCG pattern and imaging rather than on tissue. The results set a stage, from I (limited to the uterus) to IV (spread to distant organs other than the lungs), and a risk score based on factors such as age, hCG level, tumor size, time since the pregnancy, and where and how many spots of spread are found. A score of 0 to 6 is low risk, 7 to 12 is high risk, and 13 or more is ultra-high risk. The score, more than the name of the tumor, decides how intensive treatment needs to be.
Treatment is usually chemotherapy, medicine that stops tumor cells from growing and dividing. For low-risk disease, the standard first step is a single drug: methotrexate or dactinomycin (also called actinomycin D), given as injections or infusions in repeated cycles, often every two weeks. In studies, dactinomycin led to remission somewhat more often, but it more commonly causes nausea, vomiting and some hair thinning. Regular hCG tests show whether the drug is working. About 30 percent of people need to switch to the other drug, or occasionally to a combination, because hCG stops falling. Even so, cure rates for low-risk disease approach 100 percent. Two or three extra cycles are usually given after hCG becomes normal to lower the chance of relapse. High-risk disease is treated from the start with combination chemotherapy, most often a five-drug regimen known as EMA-CO after the initials of its medicines. It is more demanding, but about 9 in 10 people or more with high-risk disease are also cured. When the tumor resists treatment, other drug combinations, surgery to remove a resistant spot, and immunotherapy are options. Surgery plays a smaller role. Removing the uterus (hysterectomy) is an option for some people with low-risk disease who do not want future pregnancies, but chemotherapy and hCG monitoring are still needed afterward, so it does not replace them. A hysterectomy or a procedure that blocks blood flow through the uterine arteries (embolization) may be needed to control serious bleeding. Because GTN is uncommon, care at a center experienced with trophoblastic disease is recommended where possible.
Treatment length depends on how quickly hCG falls, and the blood tests guide each decision to continue, switch or stop. Once treatment ends, hCG is checked monthly for at least 12 months so that any relapse is caught early, when it is most treatable. Reliable contraception is needed throughout that year, because a new pregnancy would raise hCG and hide a returning tumor. Hormonal birth control is considered safe during this time. After follow-up is complete, future fertility, pregnancy and children are typically not affected. The chance of another molar pregnancy is low, about 1 to 2 in 100 after a single mole, though it is higher after repeated moles. The diagnosis usually comes soon after a pregnancy loss, and the long stretch of blood tests can be wearing. Nursing and psychosocial support help many people cope and stay on track with follow-up, which matters because missed tests are the main way a treatable tumor goes unnoticed.
If you have had a molar pregnancy and your hCG follow-up has lapsed, contact your care team to restart it, even if you feel well. Vaginal bleeding that is not a normal period, during or after follow-up, is a reason to call your care team so hCG can be rechecked. An invasive mole can grow through the wall of the uterus and damage blood vessels. Heavy vaginal bleeding, sudden severe pain in the belly or pelvis, or feeling faint or dizzy can mean serious bleeding and need emergency care right away.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Invasive Molar Pregnancy is like, what's helped you, or ask the community a question.